Nuveen Asset Management, LLC Cassava Sciences Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 162,211 shares of SAVA stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

162,211

Previous 278,534 41.76%

Holding current value

$1.91 Million

Previous $6.27 Million 47.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$18.44 - $26.41 $2.14 Million - $3.07 Million	-116,323 Reduced 41.76%	162,211 $3.29 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $1.11 Million - $2.64 Million	87,663 Added 45.93%	278,534 $6.27 Million
Q3 2023 Nov 14, 2023	SELL	$16.64 - $25.32 $812,897 - $1.24 Million	-48,852 Reduced 20.38%	190,871 $3.18 Million
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $93,959 - $121,333	4,352 Added 1.85%	239,723 $5.88 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $3,565 - $5,538	152 Added 0.06%	235,371 $5.68 Million

Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $2.25 Million - $3.57 Million	80,904 Added 52.43%	235,219 $6.95 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $90,239 - $282,157	-5,526 Reduced 3.46%	154,315 $6.45 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $1.49 Million - $3.32 Million	-86,310 Reduced 35.06%	159,841 $4.49 Million
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $284,924 - $463,657	8,740 Added 3.68%	246,151 $9.41 Million
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $3.7 Million - $9.14 Million	-100,551 Reduced 29.75%	237,411 $10.4 Million
Q3 2021 Nov 12, 2021	SELL	$41.79 - $135.3 $2.78 Million - $9 Million	-66,497 Reduced 16.44%	337,962 $21 Million
Q2 2021 Aug 16, 2021	SELL	$32.15 - $89.72 $2.36 Million - $6.58 Million	-73,382 Reduced 15.36%	404,459 $1.34 Million
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $950,215 - $11.8 Million	-134,022 Reduced 21.9%	477,841 $1.59 Million
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $3.53 Million - $6.38 Million	520,414 Added 569.08%	611,863 $2.03 Million
Q3 2020 Nov 16, 2020	SELL	$2.86 - $11.51 $92,435 - $372,003	-32,320 Reduced 26.11%	91,449 $304,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $252,488 - $1.19 Million	123,769 New	123,769 $382,000

Others Institutions Holding SAVA

# of Institutions

172

Shares Held

11.3M

Call Options Held

1.61M

Put Options Held

1.43M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $473M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cassava Sciences Inc Transaction History